A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

A research team led by Prof. Wang Haoyi from the Institute of Zoology (IOZ) of the Chinese Academy of Sciences has developed ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

Copyright: © 2024 Elsevier Ltd. Published by Elsevier Ltd. CAR T-cell therapies have revolutionised treatment of many diseases, but their expense means many patients ...

Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...

This early data has demonstrated a clear improvement in GLPG5101 efficacy over its competitors in iNHL and MCL.

For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-ce ...

These receptors allow T cells to sense and respond to diverse types of infection. Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment, but further optimization is still ...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is one of several contenders to a heretofore unclaimed crown: engineered cell ...

“Through this latest advancement, patients can receive cell therapy treatment at Tampa General on an outpatient, instead of ...